The ROE (Return on Equity) of HaTay Pharmaceutical JSC (DHT.VN) is 4.96%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2025-12-31 | 4.96% |
| 2024-12-31 | 6.97% |
| 2023-12-31 | 8.19% |
| 2022-12-31 | 12.31% |
| 2021-12-31 | 9.31% |
| 2020-12-31 | 28.22% |
| 2019-12-31 | 29.87% |
| 2018-12-31 | 32.45% |
| 2017-12-31 | 31.64% |
| 2016-12-31 | 30.52% |